腮腺腺泡细胞癌29例临床分析  

A Clinical Analysis of 29 Patients with Acinic Cell Carcinoma of Parotid

作　　者：陈福进[1] 杨安奎[1] 李秋梨[1] 曾宗渊[1] 

机构地区：[1]中山医科大学肿瘤防治中心头颈科,广东广州510060

出　　处：《癌症》2001年第6期649-650,共2页Chinese Journal of Cancer

摘　　要：目的：总结腮腺腺泡细胞癌的临床特点、生物学行为及治疗效果。方法：对２９例腮腺腺泡细胞癌病者进行临床分析。结果：腮腺腺泡细胞癌的临床特点为男女发病均等，各年龄组均可发病，好发于腮腺浅叶，生长缓慢，病程长，平均为５年，颈淋巴结转移率为１７．２％，极少发生远处转移，局部复发率为２０．７％，预后相对较好，其３、５、１０年生存率分别为 ８２． ７％、８０％和 ７６． ９％。结论：腮腺腺泡细胞癌发病少，属低度恶性肿瘤，其治疗以根治性手术切除为主，病变范围广或复发病例可行术后放疗以减少局部复发。Objective: This study was designed to summarize the clinical characteristics, biological behavior, and treatment results of acinic cell carcinoma of parotid. Method: Twenty-nine cases of acinic cell carcinoma of parotid were collected to make clinical analysis. Results: The clinical feature of acinic cell carcinoma of parotid were observed as following: the incidence of male and female was equal and happen in any age group. The tumor usual located at superficial lobe of parotid, and growth slowly. The course was long with a mean of 5 years. The incidence of cervical lymph node metastasis was 17. 2% and distant metastasis was much less, the local recurrence rate was 20. 7% and the prognosis was relatively better. The survival rates of 3-year, 5-year, 10-year were 82. 7%, 80%, and 76. 9%, respectively. Conclusion: The incidence of acinic cell carcinoma of parotid is low, and acinic cell carcinoma of parotid could be considered as lower malignant tumor. Radical surgical ressection is the most common modality for its treatment, while larger lesion or recurrent cases may receive postoperative radiotherapy so as to decrease local recurrence.

关 键 词：腮腺肿瘤 外科手术 腺泡细胞癌 病例分析 ACC 预后 

分 类 号：R739.8[医药卫生—肿瘤]